Ventripoint’s technology is a leading Artificial Intelligence (AI) approach known as Knowledge-Based Reconstruction (KBR), used to create applications to monitor heart disease, a leading cause of death worldwide. The VMS+ is the first cost-effective and accurate AI tool for measuring whole heart function using conventional ultrasound. The Company has developed a suite of applications for all major heart diseases and is actively commercializing the approach to improve cardiac care.
(TSXV:VPT, OTCQB:VPTDF)
Company’s Keywords:
cardiovascular imaging, ultrasound, echocardiography, right ventricle, four chambers of the heart, artificial intelligence, 3d, pediatrics, adult congenital, medical device
<10
<4720000
<2005
Your request has been submitted successfully.
Own or work here?